Akzidenteller Verschluß einer A. femoralis communis nach Angio-Seal TM -Applikation

Silber, Sigmund; Schön, Norbert; Seidel, N; Heiss-Bogner, J

doi:10.1007/s003920050155

Cited by 14 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All foreign bodies should be removed, including collagen plugs, sutures, and hemostatic gels. 27,28 The wound should be irrigated with antibiotic solution.…”

Section: Arterial Obstructive Complicationsmentioning

confidence: 99%

Techniques for Managing Complications of Arterial Closure Devices

Kalapatapu

Ali

Masroor

et al. 2006

Vasc Endovascular Surg

View full text Add to dashboard Cite

According to data reported by the American Heart Association, more than 5 million diagnostic and therapeutic catheterizations are performed each year in the United States. The number of catheterizations has tripled since 1979. It has been estimated that complications related to the access site result in more than 75,000 surgical procedures annually. Thus, improved management of the access site itself is essential to achieve the greater goals of improved care and reduced cost. Manual compression directly over the site of arterial puncture usually results in adequate hemostasis but has several significant drawbacks. Manual compression is uncomfortable for the patient, is fatiguing and time-consuming for staff, and necessitates several hours of costly in-hospital observation. In addition, it may be ineffective in achieving hemostasis, especially in the setting of systemic anticoagulation or following the use of large-bore devices. Based on the perceived need for an improved method of managing the arterial access site following catheterization, various vascular sealing devices have been developed. There are at least 8 (and the number is increasing) hemostatic vascular closure devices that are currently approved by the FDA for access site closure after femoral arterial catheterization. The chief advantage attributed to vascular sealing devices is accelerated access site hemostasis, even in the setting of anticoagulation, leading to earlier ambulation and hospital discharge following arterial catheterization. The most important drawbacks related to vascular sealing devices include the cost of the devices and the possibility of increased access site complications. Despite the paucity of properly designed studies supporting their use, it is estimated that over one million vascular sealing devices are used annually in the United States, a number that has increased dramatically in the past 5 years.In this review, we present a brief description of the design and function of the most widely used devices, describe the most common mechanisms of failure, and recommend strategies for management of access site complications including hemorrhage, arterial obstruction, and infection.

show abstract

“…All foreign bodies should be removed, including collagen plugs, sutures, and hemostatic gels. 27,28 The wound should be irrigated with antibiotic solution.…”

Section: Arterial Obstructive Complicationsmentioning

confidence: 99%

Techniques for Managing Complications of Arterial Closure Devices

Kalapatapu

Ali

Masroor

et al. 2006

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

“…A possible explanation is that such patients have naturally small arteries. Occlusion of the femoral artery after Angio-Seal application has been described in patients with small vessel diameter or disposition for vasospasm in previous studies 29 . Furthermore, in cachectic patients, collagen may protrude from the skin, and manipulation, pushing as well as tamping of the collagen, may result in intravascular dislocation.…”

Section: Risk Factors For Vcd-associated Complicationsmentioning

confidence: 86%